tbuckley/cabot-search huggingface dataset:
Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial
Authors: Hannah L. Rush, Laura Murphy, Alicia K. Morgans, Noel W. Clarke, Adrian D. Cook, Gerhardt Attard, Archie Macnair, David P. Dearnaley, Christopher C. Parker, J. Martin Russell, Silke Gillessen, David Matheson, Robin Millman, Christopher D. Brawley, Cheryl Pugh, Jacob S. Tanguay, Robert J. Jones, John Wagstaff, Sarah Rudman, Joe M. O'Sullivan, Joanna Gale, Alison Birtle, Andrew Protheroe, Emma Gray, Carla Perna, Shaun Tolan, Neil McPhail, Zaf I. Malik, Salil Vengalil, David Fackrell, Peter Hoskin, Matthew R. Sydes, Simon Chowdhury, Duncan C. Gilbert, Mahesh K. B. Parmar, Nicholas D. James, Ruth E. Langley
Journal: Journal of Clinical Oncology (2021)

PURPOSE Docetaxel and abiraterone acetate plus prednisone or prednisolone (AAP) both improve survival when commenced alongside standard of care (SOC) androgen deprivation therapy in locally advanced or metastatic hormone-sensitive prostate cancer. Thus, patient-reported quality of life (QOL) data may guide treatment choices. METHODS A group of patients within the STAMPEDE trial were contemporaneously enrolled with the possibility of being randomly allocated to receive either docetaxel + SOC or AAP + SOC. A mixed-model assessed QOL in those who had completed at least one QLQ-C30 + PR25 questionnaire. The primary outcome measure was difference in global-QOL (QLQ-C30 Q29&amp;30) between patients allocated to docetaxel + SOC or AAP + SOC over the 2 years after random assignment, with a predefined criterion for clinically meaningful difference of &gt; 4.0 points. Secondary outcome measures included longitudinal comparison of functional domains, pain, and fatigue, plus global-QOL at defined timepoints. RESULTS Five hundred fifteen patients (173 docetaxel + SOC and 342 AAP + SOC) were included. Baseline characteristics, proportion of missing data, and mean baseline global-QOL scores (docetaxel + SOC 77.8 and AAP + SOC 78.0) were similar. Over the 2 years following random assignment, the mean modeled global-QOL score was +3.9 points (95% CI, +0.5 to +7.2; P = .022) higher in patients allocated to AAP + SOC. Global-QOL was higher for patients allocated to AAP + SOC over the first year (+5.7 points, 95% CI, +3.0 to +8.5; P &lt; .001), particularly at 12 (+7.0 points, 95% CI, +3.0 to +11.0; P = .001) and 24 weeks (+8.3 points, 95% CI, +4.0 to +12.6; P &lt; .001). CONCLUSION Patient-reported QOL was superior for patients allocated to receive AAP + SOC, compared with docetaxel + SOC over a 2-year period, narrowly missing the predefined value for clinical significance. Patients receiving AAP + SOC reported clinically meaningful higher global-QOL scores throughout the first year following random assignment.
IMPACT OF CHRONIC KIDNEY DISEASE ON CLINICAL OUTCOMES OF CATHTER ABLATION OF VENTRICULAR TACHYCARDIA. A NATIONWIDE ANALYSIS
Authors: Mahmoud Khalil, Ahmed M. Maraey, Amro Aglan, Ahmed Elzanaty, Emmanuel Akintoye, Ayman Saeyeldin, Chirag R. Barbhaiya, Mohamed Shokr
Journal: Journal of the American College of Cardiology (2022)
Microbiology of bile aspirates obtained at ERCP in patients with suspected acute cholangitis
Authors: Mark A. Gromski, Aditya Gutta, Glen A. Lehman, Yan Tong, Evan L. Fogel, James L. Watkins, Jeffrey J. Easler, Benjamin L. Bick, Lee McHenry, Cole Beeler, Ryan F. Relich, Bryan H. Schmitt, Stuart Sherman
Journal: Endoscopy (2022)

The cornerstone of treatment for acute cholangitis is source control with biliary drainage and early antibiotics. The primary aim of this study was to describe the microbiology of bile aspirate pathogens obtained at the time of endoscopic retrograde cholangiopancreatography (ERCP) in patients suspected of having acute cholangitis.In this single-center retrospective study, patients were included if a bile aspirate was collected at ERCP for suspicion of acute cholangitis, from 1 January 2010 to 31 December 2016.There were 721 ERCP procedures for suspected acute cholangitis with bile culture results, with 662 positive bile cultures (91.8 %). Pathogens included: Enterococcus species (spp.) 448 (67.7 %); Klebsiella spp. 295 (44.6 %); Escherichia coli 269 (40.6 %); Pseudomonas spp. 52 (7.9 %); and anaerobes 64 (9.7 %). Susceptibility of Klebsiella pneumoniae and E.coli isolates to ciprofloxacin was 88 % and 64 %, respectively. Extended-spectrum beta-lactamases and carbapenem resistance were found in 7.9 % and 3.6 % of Enterobacteriaceae, respectively. There were 437 concurrent blood cultures, of which 174 were positive (39.8 % of cultures drawn). Prior biliary endoscopic sphincterotomy (ES) was evident in 459 ERCP cases (63.7 %), and was associated with increased frequency of Klebsiella spp., Pseudomonas aeruginosa, Enterobacter spp., and Enterococcus spp. Prior biliary ES significantly increased the probability of vancomycin-resistant Enterococcus (VRE).The vast majority of bile cultures (91.8 %) were positive. The susceptibilities of E.coli and K.pneumoniae to ciprofloxacin are lower than historically noted. A notable portion of cultures contained pathogenic drug-resistant organisms. Prior biliary ES is associated with a higher frequency of certain organisms and higher frequency of VRE.
Development of Myocardial Fat in Patients With Acute Myocardial Infarction Determined by Cardiac Computed Tomography
Authors: Josefine Windfeld-Mathiasen, Martina Chantal de Knegt, Per Ejlstrup Sigvardsen, Jesper James Linde, Lars Køber, Klaus Fuglsang Kofoed, Jørgen Tobias Kühl
Journal: JACC. Cardiovascular imaging (2022)
IFN-γ Levels Prior to Endoscopic Sinus Surgery are Correlated with Post-Surgical Patient Reported Outcome Measures in Patients with Chronic Rhinosinusitis with Nasal Polyps
Authors: Eli Stein, Alexander Schneider, Samuel Racette, Abhita Reddy, Julia Huang, David Lehmann, Caroline Price, Jacob Eide, David Conley, Kevin Welch, Robert Kern, Stephanie Shintani-Smith, Anju Peters, Atsushi Kato, Whitney Stevens, Robert Schleimer, Bruce Tan
Journal: Journal of Allergy and Clinical Immunology (2022)
p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade
Authors: David P. Molkentine, Jessica M. Molkentine, Kathleen A. Bridges, David R. Valdecanas, Annika Dhawan, Reshub Bahri, Andrew J. Hefner, Manish Kumar, Liangpeng Yang, Mohamed Abdelhakiem, Phillip M. Pifer, Vlad Sandulache, Aakash Sheth, Beth M. Beadle, Howard D. Thames, Kathryn A. Mason, Curtis R. Pickering, Raymond E. Meyn, Heath D. Skinner
Journal: Cancer Research (2021)

Squamous cell carcinoma driven by human papillomavirus (HPV) is more sensitive to DNA-damaging therapies than its HPV-negative counterpart. Here, we show that p16, the clinically used surrogate for HPV positivity, renders cells more sensitive to radiotherapy via a ubiquitin-dependent signaling pathway, linking high levels of this protein to increased activity of the transcription factor SP1, increased HUWE1 transcription, and degradation of ubiquitin-specific protease 7 (USP7) and TRIP12. Activation of this pathway in HPV-positive disease led to decreased homologous recombination and improved response to radiotherapy, a phenomenon that can be recapitulated in HPV-negative disease using USP7 inhibitors in clinical development. This p16-driven axis induced sensitivity to PARP inhibition and potentially leads to "BRCAness" in head and neck squamous cell carcinoma (HNSCC) cells. Thus, these findings support a functional role for p16 in HPV-positive tumors in driving response to DNA damage, which can be exploited to improve outcomes in both patients with HPV-positive and HPV-negative HNSCC.
SEX DISPARITIES IN ST-ELEVATION MYOCARDIAL INFARCTION WITH NONOBSTRUCTIVE CORONARY ARTERIES (MINOCA)
Authors: Odayme Quesada, Mehmet Yildiz, Anaya Shah, Brynn Okeson, Jenny Chambers, Lucas Volpenhein, Rebekah Lantz, Dalia Aziz, Ross Garberich, Heather Rohm, Frank V. Aguirre, Santiago Garcia, Scott W. Sharkey, Timothy D. Henry
Journal: Journal of the American College of Cardiology (2022)
High-Flow Oxygen vs Conventional Oxygen and Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19
Authors: Jie Li, Ivan Pavlov, Stephan Ehrmann
Journal: JAMA (2022)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Identification of clinical features affecting diagnostic delay in paediatric hidradenitis suppurativa: results from a multicentre observational study
Authors: Antonella Di Cesare, Georgios Nikolakis, Theodora Kanni, Evangelos J. Giamarellos-Bourboulis, Lukasz Matusiak, Jacek C. Szepietowski, Christos C. Zouboulis, Francesca Prignano
Journal: British Journal of Dermatology (2022)

Dear Editor, Hidradenitis suppurativa (HS) is a chronic recurrent immune‐mediated skin disease usually observed during the second and third decades of life, but it can also occur in children and adolescents. HS has an unpredictable course and is challenging to treat due to the limited therapeutic options and long diagnostic delay.1 It is not surprising that patients with younger age at disease onset and with severe forms are at risk of higher disease burden.2 Thus, we aimed to better characterize the clinical features of paediatric‐onset HS. Data from 56 patients with HS (28 male, 28 female) aged ≤ 18 years, from four different European Union centres were collected and analysed (Table 1). Informed consent was obtained from each participant in the study, which was approved by local ethic committees (IRB approval numbers CEAVC 19799, Florence, Italy; AKS‐A 20/16, Dessau, Germany; A12, Attikon University General Hospital, Athens, Greece; KB‐520/2018, Wroclaw, Poland).
Additional Information Section Added
Journal: JAMA Network Open (2022)

Sara Pusceddu, MD; Natalie Prinzi, MD; Salvatore Tafuto, MD; Toni Ibrahim, BSc, MD, PhD; Angelina Filice, MD; Maria Pia Brizzi, MD; Francesco Panzuto, MD, PhD; Sergio Baldari, MD; Chiara M. Grana, MD; Davide Campana, MD, PhD; Maria Vittoria Davì, MD; Dario Giuffrida, MD; Maria Chiara Zatelli, MD, PhD; Stefano Partelli, MD, PhD; Paola Razzore, MD; Riccardo Marconcini, MD, PhD; Sara Massironi, MD; Fabio Gelsomino, MD; Antongiulio Faggiano, MD, PhD; Elisa Giannetta, MD; Emilio Bajetta, MD; Franco Grimaldi, MD; Mauro Cives, MD; Fernando Cirillo, MD; Vittorio Perfetti, MD; Francesca Corti, MD; Claudio Ricci, MD; Luca Giacomelli, PhD; Luca Porcu, PhD; Massimo Di Maio, MD; Ettore Seregni, MD; Marco Maccauro, MD; Secondo Lastoria, MD; Alberto Bongiovanni, MD; Annibale Versari, MD; Irene Persano, MD; Maria Rinzivillo, MD; Salvatore Antonio Pignata, MD; Paola Anna Rocca, MD; Giuseppe Lamberti, MD; Sara Cingarlini, MD; Ivana Puliafito, MD; Maria Rosaria Ambrosio, MD; Isabella Zanata, MD; Alessandra Bracigliano, MD; Stefano Severi, MD; Francesca Spada, MD; Valentina Andreasi, MD; Roberta Modica, MD, PhD; Federica Scalorbi, MD; Massimo Milione, MD, PhD; Giovanna Sabella, MD; Jorgelina Coppa, MD; Riccardo Casadei, MD; Maria Di Bartolomeo, MD; Massimo Falconi, MD; Filippo de Braud, MD
Risk of liver‐related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease
Authors: Xinrong Zhang, Grace Lai‐Hung Wong, Terry Cheuk‐Fung Yip, Johnny T. K. Cheung, Yee‐Kit Tse, Vicki Wing‐Ki Hui, Huapeng Lin, Jimmy Che‐To Lai, Henry Lik‐Yuen Chan, Alice Pik‐Shan Kong, Vincent Wai‐Sun Wong
Journal: Hepatology (2022)

Abstract Background and Aims Several guidelines recommend screening for NAFLD in patients with type 2 diabetes (T2D). We aimed to determine if there is a threshold of age and duration of T2D for liver‐related event development to guide screening strategies. Approach and Results We conducted a territory‐wide retrospective cohort study of adult patients with NAFLD and T2D diagnosed between 2000 and 2014 in Hong Kong to allow for at least 5 years of follow‐up. The primary endpoint was liver‐related events, defined as a composite of HCC and cirrhotic complications. This study included 7028 patients with NAFLD with T2D (mean age, 56.1 ± 13.3 years; 3363 male [47.9%]). During a follow‐up of 77,308 person‐years, there was a threshold effect with 1.1%, 4.9%, and 94.0% of patients developing liver‐related events at the age of &lt;40, 40–50, and ≥50 years, respectively. Similarly, 3.1%, 5.1%, and 91.8% of patients developed cirrhosis at the age of &lt;40, 40–50, and ≥50 years, respectively. In contrast, liver‐related events increased linearly with diabetes duration, with no difference in the annual incidence rate between the first 10 years of T2D diagnosis and subsequent years (0.06% vs. 0.10%; p = 0.136). On multivariable analysis, baseline age ≥50 years (adjusted HR [aHR] 2.01) and cirrhosis (aHR 3.12) were the strongest risk factors associated with liver‐related events. Substitution of cirrhosis with the aspartate aminotransferase‐to‐platelet ratio index or the Fibrosis‐4 index yielded similar results. Conclusions Age rather than duration of T2D predicts liver‐related events in patients with NAFLD and T2D. It is reasonable to screen patients with NAFLD and T2D for advanced liver disease starting at 50 years of age.
THE EFFECT OF BETA-BLOCKER MEDICATIONS POST MYOCARDIAL INFARCTION WITH EJECTION FRACTION &gt;40%: POOLED ANALYSIS DATA FROM SEVEN ARABIAN GULF ACS REGISTRY
Authors: Rasha Al-Bawardy, Wael Alqarawi, Jassim AlSuwaidi, Wael Almahmeed, Mohammad Zubaid, Haitham Amin, Kadhim Sulaiman, Khalid F. AlHabib
Journal: Journal of the American College of Cardiology (2022)
Effects of Trunk Inclination on Respiratory Mechanics in Patients with COVID-19–associated Acute Respiratory Distress Syndrome: Let’s Always Report the Angle!
Authors: Francesco Marrazzo, Stefano Spina, Clarissa Forlini, Marcello Guarnieri, Riccardo Giudici, Gabriele Bassi, Luca Bastia, Maurizio Bottiroli, Roberto Fumagalli, Thomas Langer
Journal: American Journal of Respiratory and Critical Care Medicine (2022)
Targeting Stearoyl-CoA Desaturase in Solid Tumors
Authors: Casie S. Kubota, Peter J. Espenshade
Journal: Cancer Research (2022)

Abstract Cancer cells are demarcated from normal cells by distinct biological hallmarks, including the reprogramming of metabolic processes. One of the key players involved in metabolic reprogramming is stearoyl-CoA desaturase (SCD), which converts saturated fatty acids to monounsaturated fatty acids in an oxygen-dependent reaction that is crucial for maintaining fatty acid homeostasis. As such, SCD has been identified as a potential therapeutic target in numerous types of cancers, and its inhibition suppresses cancer cell growth in vitro and in vivo. This review summarizes the evidence implicating SCD in cancer progression and proposes novel therapeutic strategies for targeting SCD in solid tumors.
EFFECT OF SEX AND LOW FLOW AFTER SURGICAL OR TRANSCATHETER AORTIC VALVE REPLACEMENT: AN ANALYSIS OF PARTNER 2 AND 3 TRIALS
Authors: Marie-Annick Clavel, Rebecca T. Hahn, Amr E. Abbas, Melissa A. Daubert, Pamela S. Douglas, Sammy Elmariah, Yanglu Zhao, Michael J. Mack, Martin B. Leon, Philippe Pibarot
Journal: Journal of the American College of Cardiology (2022)
INITIAL EXPERIENCE WITH LITHOTRIPSY FOR MITRAL BALLOON VALVULOPLASTY
Authors: David Gelovani, Shazil Mahmood, Dee Dee Wang, Tiberio M. Frisoli, James Chihong Lee, Pedro Arturo Villablanca, Michael Chiang, Pedro Engel-Gonzales, Janet Fredal Wyman, Brian O’Neill, William W. O’Neill, Marvin H. Eng
Journal: Journal of the American College of Cardiology (2022)
EDP-938, a Respiratory Syncytial Virus Inhibitor, in a Human Virus Challenge
Authors: Alaa Ahmad, Kingsley Eze, Nicolas Noulin, Veronika Horvathova, Bryan Murray, Mark Baillet, Laura Grey, Julie Mori, Nathalie Adda
Journal: New England Journal of Medicine (2022)

Respiratory syncytial virus (RSV) infection causes substantial morbidity and mortality among infants, older adults, and immunocompromised adults. EDP-938, a nonfusion replication inhibitor of RSV, acts by modulating the viral nucleoprotein.
CAROTID THERMAL HETEROGENEITY DETECTED BY MICROWAVE RADIOMETRY IS ASSOCIATED WITH THIN CAP FIBROATHEROMA AND PLAQUE RUPTURE IN PATIENTS PRESENTING WITH ACUTE MYOCARDIAL INFARCTION
Authors: Pavlos Bounas, Antonios Karanasos, Andreas G. Synetos, Angelos Papanikolaou, George Latsios, Maria I. Drakopoulou, George Trantalis, Christopher D. Olympios, Dimitris Tousoulis, Konstantinos P. Toutouzas
Journal: Journal of the American College of Cardiology (2022)
CLASSIFICATION OF LEFT VENTRICULAR EJECTION FRACTION THROUGH DEEP LEARNING OF MEASURING AORTIC PRESSURE SIGNAL DURING CARDIAC CATHETERIZATION
Authors: Chiehyu Chang, Hong-Yih Tseng, I-Chang Hsieh, Chun-Chi Chen, Ming-Jer Hsieh, Chin Hsia
Journal: Journal of the American College of Cardiology (2022)
How to design high quality acupuncture trials—a consensus informed by evidence
Authors: Yu-Qing Zhang, Rui-Min Jiao, Claudia M Witt, Lixing Lao, Jian-Ping Liu, Lehana Thabane, Karen J Sherman, Mike Cummings, Dawn P Richards, Eun-Kyung Anna Kim, Tae-Hun Kim, Myeong Soo Lee, Michael E Wechsler, Benno Brinkhaus, Jun J Mao, Caroline A Smith, Wei-Juan Gang, Bao-Yan Liu, Zhi-Shun Liu, Yan Liu, Hui Zheng, Jia-Ni Wu, Alonso Carrasco-Labra, Mohit Bhandari, Philip J Devereaux, Xiang-Hong Jing, Gordon Guyatt
Journal: BMJ (2022)

An international panel including patients, clinicians, researchers, acupuncture and surgery trialists, statisticians, and experts in clinical epidemiology and methodology have developed new guidance for randomised controlled trials in acupuncture. It addresses the most prevalent and critical concerns of current acupuncture trials and will help funding agencies, trial registers, and journal editors to evaluate the relevance, importance, and quality of submitted trial proposals and completed trials
BIVENTRICULAR PACING-INDUCED LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION IN A FEMALE WITH ADVANCED HEART FAILURE AND LBBB: AN UNEXPECTED COMPLICATION
Authors: Sameer Acharya, Malcolm D. Brand, Janette Lee, Samjhauta Bhattarai, Leah Ells
Journal: Journal of the American College of Cardiology (2022)
ECHOCARDIOGRAPHY-BASED CONVOLUTIONAL NEURAL NETWORK ACCURATELY DIFFERENTIATES ETIOLOGIES OF INCREASED LEFT VENTRICULAR WALL THICKNESS
Authors: Chieh Ju Chao, James Shuyue Li, Jiwoong Jason Jeong, Timothy Barry, Amith R. Seri, Hana Neuman, Megan Campany, Merna Abdou, Michael O’Shea, Sean Smith, Yuxiang Wang, Steven J. Lester, Said Alsidawi, Susan Wilansky, D. Eric Steidley, Julie Rosenthal, Chadi Ayoub, Christopher P. Appleton, Win-Kuang Shen, Martha Grogan, Garvan C. Kane, Jae K. Oh, Bhavik N. Patel, Imon Banerjee, Reza Arsanjani
Journal: Journal of the American College of Cardiology (2022)
Citizen science can help to alleviate the generalizability crisis
Authors: Courtney B. Hilton, Samuel A. Mehr
Journal: Behavioral and Brain Sciences (2022)

Abstract Improving generalization in psychology will require more expansive data collection to fuel more expansive statistical models, beyond the scale of traditional lab research. We argue that citizen science is uniquely positioned to scale up data collection and, that in spite of certain limitations, can help to alleviate the generalizability crisis.
LATE TRANSCATHETER HEART VALVE THROMBOSIS WITH SEVERE AORTIC STENOSIS LEADING TO CARDIOGENIC SHOCK: A HEART TEAM APPROACH
Authors: Qasim Al Abri, Tomoya Hinohara, Su Min Chang, Nadeen Nader Faza, Moritz C. Wyler von Ballmoos, Sachin S. Goel, Neal S. Kleiman, Michael J. Reardon
Journal: Journal of the American College of Cardiology (2022)
VENTRICULAR ARRHYTHMIAS FOLLOWING TRANSCATHETER PULMONARY VALVE REPLACEMENT WITH THE HARMONY(C) TPV 25 DEVICE
Authors: Anne Taylor, Jeffrey Yang, Anne Marie Dubin, M. Henry Chubb, Kara Motonaga, William Goodyer, Heather Giacone, Lynn F. Peng, Anitra W. Romfh, Doff B. McElhinney, Scott R. Ceresnak
Journal: Journal of the American College of Cardiology (2022)
ATRIAL FIBRILLATION AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG HOSPITALIZED COVID-19 PATIENTS
Authors: Kristopher Aten, Lucas Wang, Lawrence M. Hoang, Mujahed Abualfoul, Victor Canela, Sri Pravathida, Michael Vu, Yi Zhao, Manavjot Singh Sidhu
Journal: Journal of the American College of Cardiology (2022)
Wireless Force‐Inducing Neuronal Stimulation Mediated by High Magnetic Moment Microdiscs (Adv. Healthcare Mater. 6/2022)
Authors: Claudia Collier, Nicolas Muzzio, Rohini Thevi Guntnur, Amanda Gomez, Carolina Redondo, Raquel Zurbano, Ivan K. Schuller, Carlos Monton, Rafael Morales, Gabriela Romero
Journal: Advanced Healthcare Materials (2022)

Magnetomechanical Transduction In article number 2101826 by Rafael Morales, Gabriela Romero, and co-workers, magnetic microdiscs fabricated by litography techniques are utilized to magnetically induce mechanotransduction in primary neural cultures. The red and blue colors in the microdiscs indicate a magnetic component of a special spin configuration known as vortex state.
SUB-ACUTE THROMBOSIS OF MECHANICAL MITRAL PROSTHESIS SUCCESSFULLY TREATED WITH SLOW THROMBOLYSIS IN A PATIENT WITH NONBACTERIAL THROMBOTIC ENDOCARDITIS
Authors: Christy Lougheed, Jeffrey Tran, Pooja S. Jagadish, Toshinobu Kazui, Tushar Acharya, Arka Chatterjee
Journal: Journal of the American College of Cardiology (2022)
DOES HIGHER ENERGY LEAD TO HIGHER CLOSURE RATES IN PATHOLOGIC PERFORATOR VEINS ENDOVENOUS LASER ABLATION THERAPY?
Authors: Ali F. Aboufares, Ferdouse Sartawi, Daniel Cartagena, Henry Huynh, Armon Panahi, Taha Abdullah, Teuta Berishaj, Felecia Pasram, Gisselle Salcedo, Rami Sartawi
Journal: Journal of the American College of Cardiology (2022)
Abstract 17832: Is Regadenoson Ready for Prime Time in Cardiac Rubidium82 PET/CT Stress Imaging?
Authors: Eric Harrison, Angela McClanahan, Vinod Patel, Katheryne Downes
Journal: Circulation (2010)

Introduction: Regadenoson is a selective A2A agonist which has been introduced as new pharmacological stress agent for cardiac myocardial perfusion imaging with a large experience using Single Phot...
TCTAP C-033 CHIP - Choice OR Only Option..!! For Complicated Post Covid Case With Severely Calcified LM Trifurcation Lesion
Authors: Harsimran Singh, Nagendra Boopathy Senguttuvan, Ramesh Sankaran, Vinod Kumar Balakrishnan, S. Sadhanandham, Venkata Balasubramaniyan Jayanty, Preetam Krishnamurthy, Manokar Panchanatham, Thoddi Ramamurthy Muralidharan
Journal: Journal of the American College of Cardiology (2022)